Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Uveal Melanoma × durvalumab × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 15 Carcinoma, Renal Cell 5 Carcinoma, Non-Small-Cell Lung 5 Breast Neoplasms 5 Small Cell Lung Carcinoma 4 Carcinoma, Merkel Cell 4 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Triple Negative Breast Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Prostatic Neoplasms 3 Neoplasm Metastasis 3 Lymphoma, T-Cell, Cutaneous 3 Carcinoma, Hepatocellular 3 Stomach Neoplasms 2 Sarcoma 2 Lung Neoplasms 2 Kidney Neoplasms 2 Head and Neck Neoplasms 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Transitional Cell 2 Uveal Melanoma 1 Turcot syndrome 1 Thyroid Neoplasms 1 Testicular Neoplasms 1 Skin Neoplasms 1 Sezary Syndrome 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1

Interventions

Ipilimumab 25 Nivolumab 19 pembrolizumab 11 incomplete Freund's adjuvant 10 Melphalan 9 Cyclophosphamide 9 Interleukin-2 8 sargramostim 7 MART-1 Antigen 7 CTLA-4 Antigen 7 tebentafusp 6 Temozolomide 6 Ranibizumab 6 montanide ISA 51 5 Sunitinib 5 Radiosurgery 5 Dacarbazine 5 Blood Specimen Collection 5 aldesleukin 4 aflibercept 4 Surveys and Questionnaires 4 Magnetic Resonance Spectroscopy 4 Carboplatin 4 Biopsy 4 Bevacizumab 4 trametinib 3 sotrastaurin 3 fludarabine phosphate 3 fludarabine 3 binimetinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04184518 2020-06-02

CEDUVEAL-M

Grupo Español Multidisciplinar de Melanoma

Phase 2 Withdrawn

Uveal Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡